What is the role of immunotherapy in aggressive lymphoma? What do APs need to know about managing immune-related adverse events in patients?
Paul Hamlin, MD
Memorial Sloan Kettering Cancer Center
Michelle R. Wisniewski, MS, PA-C
Memorial Sloan Kettering Cancer Center